Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ispinesib in advanced renal cell cancer
NCT00354250Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2006
- Primary completion
- Feb 2007
- Countries
- 1
01
Overview
Phase 2, open-label trial of ispinesib in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started May 2006; status: completed.
02
Drugs
ispinesib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00354250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00354250.